Aurora Cannabis Inc.
corporate_fare Company Profile
Aurora Cannabis Inc. (NASDAQ:ACB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 36 items for ACB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Aurora Cannabis Forms Special Committee in Response to Curaleaf's Hostile Bid
- Curaleaf Launches Hostile $4/Share Bid for Aurora Cannabis, 45% Premium
- Aurora Cannabis Q1 FY27: International Medical Revenue Jumps 17%, Adjusted EBITDA Falls to C$3.4M
- Aurora Cannabis Q1 FY27: Net Loss Narrows, Material Weakness Persists, $46M Cash Unlock Ahead
- Aurora Cannabis Flags Fresh Internal Control Weakness Over Biological Assets and Inventory
Financial Snapshot
Insider Transactions
ACB files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.